PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)
$2.33 0.03 (1.3043%)
Analysed PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) News Sources
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
04-09-2026
yahoo.com
Q2 Earnings Highlights: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks
08-09-2026
yahoo.com
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
17-09-2026
yahoo.com
Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push
20-09-2026
marketbeat.com
Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know
25-09-2026
yahoo.com
Why Is PacBio (PACB) Stock Soaring Today
30-09-2026
yahoo.com
Why PacBio (PACB) Stock Is Trading Up Today
06-10-2026
yahoo.com
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
06-10-2026
yahoo.com
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
08-10-2026
yahoo.com
PacBio (PACB) Stock Gets Fair Value Boost After UBS Starts Coverage Neutral
09-10-2026
yahoo.com
What is the current price of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The current price of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is $2.33.
PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) absolute price change since previous trading day?
The absolute price change of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) since the previous trading day is $0.03.
PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) percentage price change since previous trading day?
The percentage price change of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) since the previous trading day is 1.3043%.
What is the most recent average sentiment score for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The most recent average sentiment score for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The most recent sentiment for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is .
SEC-8K** Filing Available For PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.